🏛️ Verified NIH Record • Updated 2026-06-11
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (NCT05164172)
Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: H. Lundbeck A/S
🩺 Plain-English Summary (8th-Grade Level)
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
Who can join: Review the eligibility criteria below.
Location: Yale University School of Medicine — New Haven, Connecticut
Age range: 6 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (70 Sites)
Showing the first 25 of 70 sites.
- Yale University School of Medicine — New Haven, Connecticut
- Ki Health Partners LLC DBA New England Institute for Clinical Research — Stamford, Connecticut
- NW FL Clinical Research Group, LLC — Gulf Breeze, Florida
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave — Hialeah, Florida
- Axcess Medical Research — Loxahatchee Groves, Florida
- University of South Florida — Tampa, Florida
- University of Kentucky — Lexington, Kentucky
- University of Maryland School of Medicine — Baltimore, Maryland
- Michigan Head Pain and Neurological Institute — Ann Arbor, Michigan
- Michigan State University - Department of Neurology — East Lansing, Michigan
- Helen Devos Childrens' Hospital - PIN — Grand Rapids, Michigan
- Dent Neurosciences Research Center Incorporated — Amherst, New York
- True North Neurology — Commack, New York
- OnSite Clinical Solutions, LLC - Randolph Rd - Charlotte — Charlotte, North Carolina
- Childrens Hospital Medical Center of Akron — Akron, Ohio
- Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio
- Road Runner Research Ltd — San Antonio, Texas
- Children's Specialty Group - 3 Commercial Place — Norfolk, Virginia
- Marshall University Medical Center — Huntington, West Virginia
- Children's Wisconsin - Milwaukee Campus - PIN — Milwaukee, Wisconsin
- Hospital Privado de La Comunidad — Mar del Plata, Buenos Aires
- Hospital de Niños de La Santisima Trinidad — Córdoba-Barrio Crisol, Córdoba Province
- Instituto Médico Río Cuarto — Río Cuarto, Córdoba Province
- INECO Neurociencias Oroño — Rosario, Santa Fe Province
- Centro de Investigaciones Médicas Tucumán - PPDS — San Miguel de Tucumán, Tucumán Province
📞 Contact the Study Coordinator
Phone: (453) 630-1311
Email: HQ_Medinfo@Lundbeck.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine
- A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
- Treatment for Migraine and Mood — The Bronx, New York
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
- A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
- Migraine Manager (R01) — Cincinnati, Ohio
- Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey
Explore by condition: All Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.